NDC 83634-301 – Eptifibatide
Eptifibatide .75 mg/mL · Injection, Solution · Intravenous
Product NDC83634-301
Product details
- Brand name
- Eptifibatide
- Generic name
- Eptifibatide
- Labeler
- Avenacy, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213081
- Marketed since
- January 31, 2024
- Marketing end
- November 30, 2027
- Pharmacologic class
- Platelet Aggregation Inhibitor
Active ingredients
- Eptifibatide .75 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83634-301-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83634-301-51) / 100 mL in 1 VIAL, SINGLE-DOSE | Jan 31, 2024 |
Other Eptifibatide products
- 83634-300 Eptifibatide 2 mg/mL · Injection, Solution · Avenacy, LLC
- 52958-040 Eptifibatide .75 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 52958-402 Eptifibatide 2 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 71288-413 Eptifibatide .75 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-412 Eptifibatide 2 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 72078-027 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 72078-026 Eptifibatide .75 mg/mL · Injection, Solution · Mylan Institutional LLC
- 72078-025 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 67457-629 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 67457-630 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 67457-631 Eptifibatide .75 mg/mL · Injection, Solution · Mylan Institutional LLC
- 25021-408 Eptifibatide .75 mg/mL · Injection, Solution · Sagent Pharmaceuticals